Advance Therapy Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Advance Therapy's estimated annual revenue is currently $13.1M per year.(i)
  • Advance Therapy's estimated revenue per employee is $243,000

Employee Data

  • Advance Therapy has 54 Employees.(i)
  • Advance Therapy grew their employee count by -7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$305.4M8086%N/AN/A
#2
$5.1M27-13%N/AN/A
#3
$24.3M90-25%N/AN/A
#4
$60.3M20317%N/AN/A
#5
$28.6M1069%N/AN/A
#6
$30M111-8%N/AN/A
#7
$84.1M283-3%N/AN/A
#8
$107.7M31923%N/AN/A
#9
$13.4M554%N/AN/A
#10
$561.4M145440%$1.1BN/A

keywords:N/A

N/A

Total Funding

54

Number of Employees

$13.1M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Advance Therapy News

2022-04-20 - Coeptis Combines with Bull Horn in SPAC Deal to Advance ...

CD38-GEAR-NK is a natural killer (NK) cell- based therapy candidate that supports combination treatment with anti-CD38 monoclonal antibodies (...

2022-04-19 - Novel CAR T Therapy for Solid Tumors: 'Exciting Advance'

Now, a new CAR T construct that targets the tumor-specific antigen claudin 6 (CLDN6) is showing promising preliminary activity against relapsed...

2022-04-13 - Cell therapy biotech raises $120M to advance therapy to treat common cornea condition

Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that affects millions of people.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M5417%N/A
#2
$11.5M54-5%$80M
#3
$13.1M54-2%N/A
#4
$6.8M542%N/A
#5
$5.5M548%N/A